Shopko Optical 107 | |
190 S 500 W, Bountiful, UT 84010-8729 | |
(801) 295-9200 | |
Not Available |
Full Name | Shopko Optical 107 |
---|---|
Type | Facility |
Speciality | Eyewear Supplier |
Location | 190 S 500 W, Bountiful, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205889078 | NPI | - | NPPES |
17929 | Other | MEDICARE | |
014107 | Other | VIP | |
UT04877 | Other | UT | NORIDIAN SUBMITTER ID |
CP2230-53 | Other | EYEMED | |
42591 | Other | DAVIS | |
35537 | Other | AVESIS | |
410985054-229 | Medicaid | UT |
Mailing Address | Practice Location Address |
---|---|
Shopko Optical 107 190 S 500 W, Bountiful, UT 84010-8729 Ph: (801) 295-9200 | Shopko Optical 107 190 S 500 W, Bountiful, UT 84010-8729 Ph: (801) 295-9200 |
News Archive
MD² International, the founders and definitive providers of concierge medicine, opened their Park Avenue practice on the Upper East Side of Manhattan with Drs. Shari Midoneck and George Ellis.
Oncotarget recently published "Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy" which reported that Chimeric antigen receptor T cell therapies, and adoptive cell therapy in general, represent one of the most promising anti-cancer strategies.
A paper published today by Science Translational Medicine outlines the process by which a category of anticancer drugs called curaxins inhibit tumor cell growth and division.
Angiotech Pharmaceuticals, Inc. today announced that its subsidiary, Angiotech Pharmaceuticals, Inc., has executed a Settlement and License Termination Agreement with Rex Medical, LP, providing for the full and final settlement and/or dismissal of all claims arising under the the License, Supply, Marketing and Distribution Agreement between Angiotech US and Rex, dated March 13, 2008.
› Verified 2 days ago